Literature DB >> 8823352

Clinical experience with risperidone.

S R Marder1.   

Abstract

Recent clinical experiences with risperidone including controlled trials, clinical observations, and reports of side effects are reviewed. The controlled trials indicate that risperidone is an effective anti-psychotic that may have advantages over conventional antipsychotics for treating both positive and negative symptoms of schizophrenia. A number of clinical reports indicate that risperidone is also effective for psychotic illnesses that result from other disorders. Risperidone has a relatively mild side effect profile when compared with conventional antipsychotics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8823352

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  4 in total

Review 1.  Risperidone: a review of its use in the management of the behavioural and psychological symptoms of dementia.

Authors:  N Bhana; C M Spencer
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

2.  Comparative efficacy of centbutindole & risperidone in schizophrenia.

Authors:  R Chandra; H Singh; P K Dalal; O P Asthana; J S Srivastava
Journal:  Indian J Psychiatry       Date:  2002-10       Impact factor: 1.759

3.  Use of the dopamine agonists bromocriptine and cabergoline in the management of risperidone-induced hyperprolactinemia in patients with psychotic disorders.

Authors:  S R Tollin
Journal:  J Endocrinol Invest       Date:  2000-12       Impact factor: 4.256

4.  Risperidone in Indian patients with schizophrenia.

Authors:  A K Agarwal; V S Bashyam; S M Channabasavanna; H S Dhavale; M A Khan; S Khanna; P V Pradhan; M Katiyar; R Rajkumar; F R Niazi; R K Jalali; R Gowrishankar; S K Mishra; O P Sood
Journal:  Indian J Psychiatry       Date:  1998-07       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.